₹38.15
1.1 (2.9%)![]()
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 37.73 | Bullish |
| 10-DMA | 37.81 | Bullish |
| 20-DMA | 37.47 | Bullish |
| 50-DMA | 37.19 | Bullish |
| 100-DMA | 33.97 | Bullish |
| 200-DMA | 33.64 | Bullish |
%
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Net Sales | 25,755 | 26,768 | 27,032 | 30,742 | 30,765 |
| Total Expenditure | 25,227 | 26,339 | 27,403 | 28,143 | 26,979 |
| Other Income | 184 | 218 | 240 | 262 | 357 |
| Operating Profit | 713 | 646 | -131 | 2,861 | 4,143 |
| Interest | 661 | 634 | 650 | 579 | 498 |
| Depreciation | 1,095 | 1,112 | 1,170 | 1,269 | 1,210 |
| Profit Before Tax | -1,175 | -1,100 | -2,036 | 649 | 2,357 |
| Consolidated Net Profit | -863 | -684 | -1,356 | 373 | 1,502 |
| Adjusted EPS | -5 | -4 | -8 | 2 | 9 |
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 164 | 164 | 164 | 164 | 164 |
| Total Reserves | 7,990 | 8,784 | 9,447 | 10,930 | 10,836 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 3,159 | 3,396 | 3,321 | 4,018 | 4,659 |
| Other Current Liabilities | 2,191 | 2,074 | 1,737 | 2,059 | 2,200 |
| Short Term Borrowings | 4,702 | 4,221 | 4,729 | 5,562 | 4,641 |
| Total Liabilities | 20,148 | 20,438 | 21,089 | 24,323 | 24,248 |
| Capital Work in Progress | 88 | 71 | 77 | 86 | 156 |
| Long Term Loans & Advances | 403 | 408 | 349 | 970 | 354 |
| Currents Investments | --- | --- | --- | 12 | --- |
| Short Term Loans and Advances | 554 | 405 | 402 | 500 | 388 |
| Total Current Assets | 9,973 | 9,808 | 10,001 | 12,007 | 11,917 |
| Total Assets | 20,148 | 20,438 | 21,089 | 24,323 | 24,248 |
| Adjusted Book Value | 50 | 55 | 59 | 68 | 67 |
Investment Calculator
| Symbol | Change% |
|---|---|
| SUMICHEM | 502.3(14%) |
| ZENSARTECH | 516.1(10%) |
| AEGISVOPAK | 257.43(10%) |
| ECLERX | 1488.8(7%) |
| KAYNES | 3333.8(6%) |
Get Your Portfolio Reviewed

Stay Updated with Our Market Newsletters